Literature DB >> 1509401

Tumor necrosis factor induces von Willebrand factor release in healthy humans.

T van der Poll1, S J van Deventer, G Pasterkamp, J A van Mourik, H R Büller, J W ten Cate.   

Abstract

Tumor necrosis factor (TNF) is an important mediator of the host responses to systemic infection. To investigate the effect of TNF on the release of von Willebrand factor (vWF) into the circulation, we performed a controlled study in six healthy men, sequentially measuring the plasma concentrations of vWF antigen after a bolus intravenous injection of recombinant human TNF (50 micrograms/m2). TNF induced a marked increase in vWF antigen plasma levels, becoming significant after 45 min and peaking after 4 h (percentage increase from base line: 351 +/- 46; p less than 0.0001, TNF versus saline). The multimeric organization of circulating vWF was not affected by TNF. We conclude that TNF may be an early mediator of increased vWF secretion in systemic infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1509401

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation.

Authors:  Petros Zezos; Georgia Papaioannou; Nikolaos Nikolaidis; Themistoclis Vasiliadis; Olga Giouleme; Nikolaos Evgenidis
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

Authors:  V Fiorelli; R Gendelman; F Samaniego; P D Markham; B Ensoli
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

3.  Human neutrophil peptide-1 inhibits thrombus formation under arterial flow via its terminal free cysteine thiols.

Authors:  Jenny K McDaniel; Mohammad S Abdelgawwad; Audra Hargett; Matthew B Renfrow; Khalil Bdeir; Wenjing Cao; Douglas B Cines; X Long Zheng
Journal:  J Thromb Haemost       Date:  2019-03-13       Impact factor: 5.824

4.  Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

Authors:  A D Blann; C N McCollum
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

5.  Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.

Authors:  Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

6.  Determination of Interleukin-6 and Tumor Necrosis Factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia.

Authors:  J Tavakkol Afshari; N Ghomian; A Shameli; M T Shakeri; M A Fahmidehkar; E Mahajer; R Khoshnavaz; M Emadzadeh
Journal:  BMC Pregnancy Childbirth       Date:  2005-11-01       Impact factor: 3.007

7.  Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction.

Authors:  Yan Li; Liqun Li; Fengyun Dong; Ling Guo; Yinglong Hou; Hesheng Hu; Suhua Yan; Xiaojun Zhou; Lin Liao; Thaddeus D Allen; J U Liu
Journal:  Exp Ther Med       Date:  2015-09-01       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.